| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 32.310 | 55.892 | 78.338 | 95.469 | 129.413 | 111.883 | 144.755 | 169.412 | 193.906 | 239.749 |
| Total Income - EUR | 32.310 | 55.892 | 78.338 | 95.469 | 129.457 | 113.152 | 175.108 | 169.445 | 193.937 | 239.749 |
| Total Expenses - EUR | 24.412 | 30.893 | 48.466 | 53.975 | 72.549 | 72.878 | 111.929 | 87.210 | 94.137 | 110.300 |
| Gross Profit/Loss - EUR | 7.898 | 24.999 | 29.872 | 41.494 | 56.908 | 40.274 | 63.180 | 82.235 | 99.800 | 129.449 |
| Net Profit/Loss - EUR | 7.898 | 23.881 | 29.085 | 40.541 | 55.603 | 39.201 | 61.462 | 80.574 | 97.898 | 110.038 |
| Employees | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dermaceutica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 19.855 | 16.978 | 13.049 | 41.928 | 81.297 | 65.920 | 26.745 | 48.334 | 55.814 | 64.102 |
| Current Assets | 12.474 | 17.988 | 31.641 | 45.488 | 49.443 | 31.542 | 60.882 | 39.589 | 50.559 | 180.413 |
| Inventories | 0 | 0 | 0 | 0 | 9.902 | 9.259 | 13.529 | 17.282 | 13.758 | 15.825 |
| Receivables | 6.764 | 8.124 | 8.478 | 8.818 | 7.067 | 8.391 | 847 | 5.555 | 19.714 | 83.737 |
| Cash | 5.710 | 9.864 | 23.163 | 36.670 | 32.474 | 13.891 | 46.507 | 16.753 | 17.087 | 80.851 |
| Shareholders Funds | 9.931 | 33.711 | 43.392 | 65.041 | 115.225 | 89.746 | 81.125 | 82.449 | 97.947 | 110.087 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 22.398 | 1.255 | 1.298 | 22.375 | 15.515 | 7.716 | 6.637 | 5.569 | 8.427 | 134.479 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermaceutica Srl